These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2264160)

  • 21. High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia.
    Pan SY; Yang R; Han YF; Dong H; Feng XD; Li N; Geng W; Ko KM
    Acta Pharmacol Sin; 2006 Jun; 27(6):673-8. PubMed ID: 16723084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.
    Pasalić D; Sertić J; Kunović B; Milicević Z; Pasić A; Zrinski-Topić R; Ferencak G; Stavljenić-Rukavina A
    Croat Med J; 2001 Oct; 42(5):517-22. PubMed ID: 11593500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T; Miura K; Kajioka T; Kitahara Y
    Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ethinyl-estradiol on the biosynthesis and esterification of fatty acids in the rat liver].
    Sanfirova VM; Timov VN; Rulin VA
    Vopr Med Khim; 1984; 30(2):81-7. PubMed ID: 6146227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the epsilon 2 allele of APOE gene to hypertriglyceridemia and to early-onset alcoholic cirrhosis.
    Hernández-Nazará ZH; Ruiz-Madrigal B; Martínez-López E; Roman S; Panduro A
    Alcohol Clin Exp Res; 2008 Apr; 32(4):559-66. PubMed ID: 18241317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of hypertriglyceridemia and response to treatment with insulin in llamas and alpacas: 31 cases (1995-2005).
    Waitt LH; Cebra CK
    J Am Vet Med Assoc; 2008 May; 232(9):1362-7. PubMed ID: 18447783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic (primary) forms of hypertriglyceridemia.
    Assmann G; Brewer HB
    Am J Cardiol; 1991 Jul; 68(3):13A-16A. PubMed ID: 1853844
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypertriglyceridemia and LMF 1: Another piece of the puzzle].
    Valdivielso P
    Clin Investig Arterioscler; 2015; 27(5):253-5. PubMed ID: 26398545
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome.
    Šilhavý J; Mlejnek P; Šimáková M; Malínská H; Marková I; Hüttl M; Miklánková D; Kazdová L; Vrbacký M; Pecinová A; Mráček T; Pravenec M
    Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats.
    Vecera R; Poruba M; Hüttl M; Malinska H; Oliyarnyk O; Markova I; Racova Z; Soukop J; Kazdova L
    Curr Issues Mol Biol; 2022 Apr; 44(5):1889-1900. PubMed ID: 35678658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular, Metabolic and Inflammatory Changes after Ovariectomy and Estradiol Substitution in Hereditary Hypertriglyceridemic Rats.
    Pitha J; Huttl M; Malinska H; Miklankova D; Bartuskova H; Hlinka T; Markova I
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia.
    Hüttl M; Markova I; Miklankova D; Zapletalova I; Poruba M; Haluzik M; Vaněčkova I; Malinska H
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress.
    Trnovska J; Svoboda P; Pelantova H; Kuzma M; Kratochvilova H; Kasperova BJ; Dvorakova I; Rosolova K; Malinska H; Huttl M; Markova I; Oliyarnyk O; Melcova M; Skop V; Mraz M; Stemberkova-Hubackova S; Haluzik M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Vasoactive Role of Perivascular Adipose Tissue and the Sulfide Signaling Pathway in a Nonobese Model of Metabolic Syndrome.
    Cacanyiova S; Golas S; Zemancikova A; Majzunova M; Cebova M; Malinska H; Hüttl M; Markova I; Berenyiova A
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of atorvastatin with silymarin enhances hypolipidemic, antioxidant and anti-inflammatory effects in a rat model of metabolic syndrome.
    Marková I; Malínská H; Hüttl M; Miklánková D; Oliyarnyk O; Poruba M; Rácová Z; Kazdová L; Večeřa R
    Physiol Res; 2021 Mar; 70(1):33-43. PubMed ID: 33453720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Effects of Methylglyoxal on Transcriptome and Metabolic Changes in Visceral Adipose Tissue in a Prediabetic Rat Model.
    Hüttl M; Markova I; Miklankova D; Makovicky P; Pelikanova T; Šeda O; Šedová L; Malinska H
    Antioxidants (Basel); 2020 Aug; 9(9):. PubMed ID: 32878255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach.
    Markova I; Miklankova D; Hüttl M; Kacer P; Skibova J; Kucera J; Sedlacek R; Kacerova T; Kazdova L; Malinska H
    J Diabetes Res; 2019; 2019():8712979. PubMed ID: 31886287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidaemia and cardioprotection: Animal models for translational studies.
    Andreadou I; Schulz R; Badimon L; Adameová A; Kleinbongard P; Lecour S; Nikolaou PE; Falcão-Pires I; Vilahur G; Woudberg N; Heusch G; Ferdinandy P
    Br J Pharmacol; 2020 Dec; 177(23):5287-5311. PubMed ID: 31769007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.
    Malinska H; Hüttl M; Oliyarnyk O; Markova I; Poruba M; Racova Z; Kazdova L; Vecera R
    PLoS One; 2019; 14(8):e0220377. PubMed ID: 31404079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of dicarbonyl stress on the development of kidney dysfunction in metabolic syndrome - a transcriptomic and proteomic approach.
    Markova I; Hüttl M; Oliyarnyk O; Kacerova T; Haluzik M; Kacer P; Seda O; Malinska H
    Nutr Metab (Lond); 2019; 16():51. PubMed ID: 31388341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.